Jazz Pharmaceuticals (JAZZ) Inventory (2010 - 2026)

Jazz Pharmaceuticals' Inventory history runs 17 years deep, the most recent figure standing at $437.5 million for Q1 2026.

• On a quarterly basis, Inventory fell 11.22% year-over-year to $437.5 million in Q1 2026; TTM through Mar 2026 was $437.5 million, a 11.22% decrease from a year earlier, with the FY2025 full-year figure at $417.0 million, down 13.21% from the prior year.
• Inventory grew to $437.5 million in Q1 2026 per JAZZ's latest filing, from $417.0 million in the prior quarter.
• Across five years, Inventory topped out at $985.5 million in Q1 2022 and bottomed at $417.0 million in Q4 2025.
• The 5-year median for Inventory is $577.3 million (2024), against an average of $606.2 million.
• Biggest YoY gain for Inventory was 753.39% in 2022; the steepest drop was 36.01% in 2022.
• Year by year, Inventory stood at $714.1 million in 2022, then dropped by 16.39% to $597.0 million in 2023, then slipped by 19.53% to $480.4 million in 2024, then dropped by 13.21% to $417.0 million in 2025, then climbed by 4.92% to $437.5 million in 2026.
• Per Business Quant, the three latest JAZZ Inventory figures stand at $437.5 million (Q1 2026), $417.0 million (Q4 2025), and $483.1 million (Q3 2025).